Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study

BACKGROUND: Around 20–30% of all prescribed drugs are estimated to be metabolised by the cytochrome P450 (CYP) 2D6 enzyme. In a medical practice, it is usually not known whether a patient is a poor, intermediate, normal or ultra-rapid metaboliser for CYP2D6-metabolised drugs. OBJECTIVE: This study a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drugs Real World Outcomes
Main Authors: Kamenski, Gustav, Ayazseven, Seda, Berndt, Anne, Fink, Waltraud, Kamenski, Lukas, Zehetmayer, Sonja, Pühringer, Helene
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2019
Assuntos:
Original Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060981/
https://ncbi.nlm.nih.gov/pubmed/31863305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-019-00177-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares